| #52 |
Paul Glenn |
Materials Technologies |
1 |
| #52 |
Richard Lifsitz |
Hypermed Imaging |
1 |
| #52 |
Brian O'Boyle |
Crocs |
1 |
| #52 |
Allen C. Steere |
The General Hospital |
1 |
| #52 |
Jamie Tsung |
Shire Human Genetic Therapies |
1 |
| #52 |
Andrew Moss |
American Sterilizer |
1 |
| #52 |
Kris David Kahn |
— |
1 |
| #52 |
Campbell Webb |
Oracle |
1 |
| #52 |
Robert T. Naughton |
Voicify |
1 |
| #52 |
Paul Nioi |
Amgen |
1 |
| #52 |
Byeong-Moo Kim |
The General Hospital |
1 |
| #52 |
Mark Snyder |
State Street Bank And Trust |
1 |
| #52 |
Kevin G. Connors |
AT&T |
1 |
| #52 |
William Agush |
Shuttersong Incorporated |
1 |
| #52 |
Joseph Senecal |
Carrier |
1 |
| #52 |
Arthur Keigler |
Tel Nexx |
1 |
| #52 |
Adam Yie |
Roche Diagnostics Hematology |
1 |
| #52 |
Victor Campbell Webb |
Oracle |
1 |
| #52 |
David Zahniser |
Roche Diagnostics Hematology |
1 |
| #52 |
Ranjan Lal |
— |
1 |
| #52 |
Kin-Ming Lo |
Merck |
1 |
| #52 |
Paul Raynor Cheek |
— |
1 |
| #52 |
Adam Chase |
JPMorgan Chase |
1 |
| #52 |
Na Tian |
Boston University |
1 |
| #52 |
Charles W. Selvidge |
Mentor Graphics |
1 |
| #52 |
Edward J. Gotgart |
Unknown |
1 |
| #52 |
David Lester Smith |
Bose |
1 |
| #52 |
Irene Ghobrial |
Dana-Farber Cancer Institute |
1 |
| #52 |
Lisa M. Donnelly |
Depuy Mitek |
1 |
| #52 |
Alan MacCormack |
Silverthread |
1 |
| #52 |
Zukui Song |
Bose |
1 |
| #52 |
Michael Adam Scarpati |
Microsoft |
1 |
| #52 |
David T. Moy, JR. |
Lexington Medical |
1 |
| #52 |
Emile Delcourt |
Akamai Technologies |
1 |
| #52 |
Martin Acquadro |
Botulinum Toxin Research Associates |
1 |
| #52 |
Maxwell Bogue |
Wobbleworks |
1 |